[
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "RICD relies on the presence of antigen and interleukin-2 (IL-2) to induce programmed cell death in a subset of activated T cells following TCR re-engagement (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Distribute 13 mL of Ficoll Plus into each 50 mL tube through the Pasteur pipette using a 10 mL serological pipette tip and Pipette Aid (pipette by adding 3 ml aliquots of Ficoll at a time, repeat until 13 mL is added), creating a clear distinct Ficoll bottom layer under the sample/PBS mixture top layer as depicted in Figure 2 and Video 1.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Using a 5 mL serological pipette tip, gently collect the white layer of PBMC sitting at the plasma:Ficoll gradient interface and place it into a new 50 mL centrifuge tube, as shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Add 100 μL of the cell suspension into each well of the 96-well plate as shown in Figure 4 (6 wells total).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Examples are shown in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Calculations are as follows:\n\nFigure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Events recorded can be pulled from the Accuri C6 program from gates that were established during data acquisition, or from gates redrawn and established using another analysis program such as FlowJo (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  }
]